Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)

• Status: Completed
• Trial end date: 2004-07-01
• Target enrollment: 0
• Participant gender: Male

Summary

Evaluating the efficacy of 10mg vardenafil versus 10mg tadalafil in the first 45 minutes post-dosing, in an as-required regimen for 4 weeks in subjects with mild/moderate to severe ED

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Collaborator: GlaxoSmithKline
• Treatments: Tadalafil; Vardenafil Dihydrochloride

Criteria

Inclusion Criteria:

• Age between 18 and 64 years

• Heterosexual males

• Erectile dysfunction for more than 6 months

Exclusion Criteria:

• Penile anatomical abnormalities

• Spinal cord injury

• History of surgical prostatectomy